Polypharmacy in patients hospitalised for acute exacerbation of COPD

Díez-Manglano, Jesús (Universidad de Zaragoza) ; Barquero-Romero, J. ; Mena, P. A. ; Recio-Iglesias, J. ; Cabrera-Aguilar, J. ; López-García,F. ; Viu,R. B. ; Soriano, J. B.

Resumen: Chronic obstructive pulmonary disease (COPD) imposes a great burden on health systems, and the expense will increase in the years to come [1]. Medication represents a large proportion of COPD-related costs [2], and has increased by 170% over the past 20 years [3]. Inpatients with an acute exacerbation of COPD and more than four diagnoses after admission are prescribed significantly more drugs and present with polypharmacy more frequently [4]...

Idioma: Inglés

DOI: 10.1183/09031936.00014814

Año: 2014

Publicado en: European respiratory journal 44, 3 (2014), 791-794
ISSN: 0903-1936

Factor impacto JCR: 7.636 (2014)

Categ. JCR: RESPIRATORY SYSTEM rank: 4 / 57 = 0.07 (2014) - Q1 - T1

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)